TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

PIN: Laboratory Equipment Future Opportunity

Laboratory
optical and precision equipments (excl. glasses)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "PIN: Laboratory Equipment Future Opportunity". Published status: planned. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.3Bids / Report
66.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Aug 2021, 12:56 BST
Last source update5 Aug 2021, 12:56 BST
Recurring procurementNot published
ClassificationLaboratory, optical and precision equipments (excl. glasses)
Delivery area
OCIDocds-h6vhtk-02d132
What is being bought
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months). A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review. It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list. This notice is for prior information. This notice aims at reducing time limits for receipt of tenders. PIN Questionnaire: https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
What changed
From the official release history
  1. Status changed to planned
    5 Aug 2021, 12:56 BST
  2. Official notice release published
    5 Aug 2021, 12:56 BST
  3. Buyer information updated
    5 Aug 2021, 12:56 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planned
    Published valueNot published
    Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months). A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review. It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list. This notice is for prior information. This notice aims at reducing time limits for receipt of tenders. PIN Questionnaire: https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Aug 2021, 12:56 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-23690
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published